fda letter
-
BioMimetic Therapeutics Receives Filing Letter from FDA for Augment™ Bone Graft PMA
FRANKLIN, Tenn.–(BUSINESS WIRE)–BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) today announced the Food & Drug Administration (FDA) has accepted for review its…
Read More »